Global Drug-Coated Balloon for Coronary Artery Disease Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Drug-Coated Balloon for Coronary Artery Disease market size was valued at USD 454.1 million in 2023 and is forecast to a readjusted size of USD 1216 million by 2030 with a CAGR of 15.1% during review period.

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.

The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.

The Global Info Research report includes an overview of the development of the Drug-Coated Balloon for Coronary Artery Disease industry chain, the market status of Hospitals (Paclitaxel Coated, Other Coated), ASCs (Paclitaxel Coated, Other Coated), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug-Coated Balloon for Coronary Artery Disease.

Regionally, the report analyzes the Drug-Coated Balloon for Coronary Artery Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug-Coated Balloon for Coronary Artery Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Drug-Coated Balloon for Coronary Artery Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug-Coated Balloon for Coronary Artery Disease industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Paclitaxel Coated, Other Coated).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug-Coated Balloon for Coronary Artery Disease market.

Regional Analysis: The report involves examining the Drug-Coated Balloon for Coronary Artery Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug-Coated Balloon for Coronary Artery Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Drug-Coated Balloon for Coronary Artery Disease:
Company Analysis: Report covers individual Drug-Coated Balloon for Coronary Artery Disease manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug-Coated Balloon for Coronary Artery Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, ASCs).

Technology Analysis: Report covers specific technologies relevant to Drug-Coated Balloon for Coronary Artery Disease. It assesses the current state, advancements, and potential future developments in Drug-Coated Balloon for Coronary Artery Disease areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug-Coated Balloon for Coronary Artery Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Drug-Coated Balloon for Coronary Artery Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Paclitaxel Coated
    Other Coated

Market segment by Application
    Hospitals
    ASCs
    Catheterization Laboratory

Major players covered
    B. Braun
    Yinyi
    Eurocor
    Biotronic

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug-Coated Balloon for Coronary Artery Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug-Coated Balloon for Coronary Artery Disease, with price, sales, revenue and global market share of Drug-Coated Balloon for Coronary Artery Disease from 2019 to 2024.
Chapter 3, the Drug-Coated Balloon for Coronary Artery Disease competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug-Coated Balloon for Coronary Artery Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Drug-Coated Balloon for Coronary Artery Disease market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug-Coated Balloon for Coronary Artery Disease.
Chapter 14 and 15, to describe Drug-Coated Balloon for Coronary Artery Disease sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Drug-Coated Balloon for Coronary Artery Disease
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Paclitaxel Coated
        1.3.3 Other Coated
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 ASCs
        1.4.4 Catheterization Laboratory
    1.5 Global Drug-Coated Balloon for Coronary Artery Disease Market Size & Forecast
        1.5.1 Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity (2019-2030)
        1.5.3 Global Drug-Coated Balloon for Coronary Artery Disease Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 B. Braun
        2.1.1 B. Braun Details
        2.1.2 B. Braun Major Business
        2.1.3 B. Braun Drug-Coated Balloon for Coronary Artery Disease Product and Services
        2.1.4 B. Braun Drug-Coated Balloon for Coronary Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 B. Braun Recent Developments/Updates
    2.2 Yinyi
        2.2.1 Yinyi Details
        2.2.2 Yinyi Major Business
        2.2.3 Yinyi Drug-Coated Balloon for Coronary Artery Disease Product and Services
        2.2.4 Yinyi Drug-Coated Balloon for Coronary Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Yinyi Recent Developments/Updates
    2.3 Eurocor
        2.3.1 Eurocor Details
        2.3.2 Eurocor Major Business
        2.3.3 Eurocor Drug-Coated Balloon for Coronary Artery Disease Product and Services
        2.3.4 Eurocor Drug-Coated Balloon for Coronary Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Eurocor Recent Developments/Updates
    2.4 Biotronic
        2.4.1 Biotronic Details
        2.4.2 Biotronic Major Business
        2.4.3 Biotronic Drug-Coated Balloon for Coronary Artery Disease Product and Services
        2.4.4 Biotronic Drug-Coated Balloon for Coronary Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Biotronic Recent Developments/Updates

3 Competitive Environment: Drug-Coated Balloon for Coronary Artery Disease by Manufacturer
    3.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Manufacturer (2019-2024)
    3.3 Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Drug-Coated Balloon for Coronary Artery Disease by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Drug-Coated Balloon for Coronary Artery Disease Manufacturer Market Share in 2023
        3.4.2 Top 6 Drug-Coated Balloon for Coronary Artery Disease Manufacturer Market Share in 2023
    3.5 Drug-Coated Balloon for Coronary Artery Disease Market: Overall Company Footprint Analysis
        3.5.1 Drug-Coated Balloon for Coronary Artery Disease Market: Region Footprint
        3.5.2 Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Type Footprint
        3.5.3 Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Drug-Coated Balloon for Coronary Artery Disease Market Size by Region
        4.1.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2030)
        4.1.2 Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Region (2019-2030)
        4.1.3 Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2019-2030)
    4.2 North America Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030)
    4.3 Europe Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030)
    4.4 Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030)
    4.5 South America Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030)
    4.6 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
    5.2 Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Type (2019-2030)
    5.3 Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
    6.2 Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Application (2019-2030)
    6.3 Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2030)

7 North America
    7.1 North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
    7.2 North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
    7.3 North America Drug-Coated Balloon for Coronary Artery Disease Market Size by Country
        7.3.1 North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2030)
        7.3.2 North America Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
    8.2 Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
    8.3 Europe Drug-Coated Balloon for Coronary Artery Disease Market Size by Country
        8.3.1 Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2030)
        8.3.2 Europe Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Market Size by Region
        9.3.1 Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
    10.2 South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
    10.3 South America Drug-Coated Balloon for Coronary Artery Disease Market Size by Country
        10.3.1 South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2030)
        10.3.2 South America Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Market Size by Country
        11.3.1 Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Drug-Coated Balloon for Coronary Artery Disease Market Drivers
    12.2 Drug-Coated Balloon for Coronary Artery Disease Market Restraints
    12.3 Drug-Coated Balloon for Coronary Artery Disease Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Drug-Coated Balloon for Coronary Artery Disease and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Drug-Coated Balloon for Coronary Artery Disease
    13.3 Drug-Coated Balloon for Coronary Artery Disease Production Process
    13.4 Drug-Coated Balloon for Coronary Artery Disease Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Drug-Coated Balloon for Coronary Artery Disease Typical Distributors
    14.3 Drug-Coated Balloon for Coronary Artery Disease Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. B. Braun Basic Information, Manufacturing Base and Competitors
    Table 4. B. Braun Major Business
    Table 5. B. Braun Drug-Coated Balloon for Coronary Artery Disease Product and Services
    Table 6. B. Braun Drug-Coated Balloon for Coronary Artery Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. B. Braun Recent Developments/Updates
    Table 8. Yinyi Basic Information, Manufacturing Base and Competitors
    Table 9. Yinyi Major Business
    Table 10. Yinyi Drug-Coated Balloon for Coronary Artery Disease Product and Services
    Table 11. Yinyi Drug-Coated Balloon for Coronary Artery Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Yinyi Recent Developments/Updates
    Table 13. Eurocor Basic Information, Manufacturing Base and Competitors
    Table 14. Eurocor Major Business
    Table 15. Eurocor Drug-Coated Balloon for Coronary Artery Disease Product and Services
    Table 16. Eurocor Drug-Coated Balloon for Coronary Artery Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Eurocor Recent Developments/Updates
    Table 18. Biotronic Basic Information, Manufacturing Base and Competitors
    Table 19. Biotronic Major Business
    Table 20. Biotronic Drug-Coated Balloon for Coronary Artery Disease Product and Services
    Table 21. Biotronic Drug-Coated Balloon for Coronary Artery Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Biotronic Recent Developments/Updates
    Table 23. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 24. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 25. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 26. Market Position of Manufacturers in Drug-Coated Balloon for Coronary Artery Disease, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 27. Head Office and Drug-Coated Balloon for Coronary Artery Disease Production Site of Key Manufacturer
    Table 28. Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Type Footprint
    Table 29. Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Application Footprint
    Table 30. Drug-Coated Balloon for Coronary Artery Disease New Market Entrants and Barriers to Market Entry
    Table 31. Drug-Coated Balloon for Coronary Artery Disease Mergers, Acquisition, Agreements, and Collaborations
    Table 32. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2024) & (K Units)
    Table 33. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Region (2025-2030) & (K Units)
    Table 34. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Region (2019-2024) & (USD Million)
    Table 35. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Region (2025-2030) & (USD Million)
    Table 36. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2019-2024) & (US$/Unit)
    Table 37. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2025-2030) & (US$/Unit)
    Table 38. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
    Table 39. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
    Table 40. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Type (2019-2024) & (USD Million)
    Table 41. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Type (2025-2030) & (USD Million)
    Table 42. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2024) & (US$/Unit)
    Table 43. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2025-2030) & (US$/Unit)
    Table 44. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
    Table 45. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
    Table 46. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Application (2019-2024) & (USD Million)
    Table 47. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Application (2025-2030) & (USD Million)
    Table 48. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2024) & (US$/Unit)
    Table 49. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2025-2030) & (US$/Unit)
    Table 50. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
    Table 51. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
    Table 52. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
    Table 53. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
    Table 54. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2024) & (K Units)
    Table 55. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2025-2030) & (K Units)
    Table 56. North America Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2019-2024) & (USD Million)
    Table 57. North America Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2025-2030) & (USD Million)
    Table 58. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
    Table 59. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
    Table 60. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
    Table 61. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
    Table 62. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2024) & (K Units)
    Table 63. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2025-2030) & (K Units)
    Table 64. Europe Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2019-2024) & (USD Million)
    Table 65. Europe Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2025-2030) & (USD Million)
    Table 66. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
    Table 67. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
    Table 68. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
    Table 69. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
    Table 70. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2024) & (K Units)
    Table 71. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Region (2025-2030) & (K Units)
    Table 72. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Region (2019-2024) & (USD Million)
    Table 73. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Region (2025-2030) & (USD Million)
    Table 74. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
    Table 75. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
    Table 76. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
    Table 77. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
    Table 78. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2024) & (K Units)
    Table 79. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Country (2025-2030) & (K Units)
    Table 80. South America Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2019-2024) & (USD Million)
    Table 81. South America Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Country (2025-2030) & (USD Million)
    Table 82. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
    Table 83. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
    Table 84. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
    Table 85. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
    Table 86. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2024) & (K Units)
    Table 87. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity by Region (2025-2030) & (K Units)
    Table 88. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Region (2019-2024) & (USD Million)
    Table 89. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Region (2025-2030) & (USD Million)
    Table 90. Drug-Coated Balloon for Coronary Artery Disease Raw Material
    Table 91. Key Manufacturers of Drug-Coated Balloon for Coronary Artery Disease Raw Materials
    Table 92. Drug-Coated Balloon for Coronary Artery Disease Typical Distributors
    Table 93. Drug-Coated Balloon for Coronary Artery Disease Typical Customers
List of Figures
    Figure 1. Drug-Coated Balloon for Coronary Artery Disease Picture
    Figure 2. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Type in 2023
    Figure 4. Paclitaxel Coated Examples
    Figure 5. Other Coated Examples
    Figure 6. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Application in 2023
    Figure 8. Hospitals Examples
    Figure 9. ASCs Examples
    Figure 10. Catheterization Laboratory Examples
    Figure 11. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity (2019-2030) & (K Units)
    Figure 14. Global Drug-Coated Balloon for Coronary Artery Disease Average Price (2019-2030) & (US$/Unit)
    Figure 15. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Manufacturer in 2023
    Figure 16. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Manufacturer in 2023
    Figure 17. Producer Shipments of Drug-Coated Balloon for Coronary Artery Disease by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 18. Top 3 Drug-Coated Balloon for Coronary Artery Disease Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Top 6 Drug-Coated Balloon for Coronary Artery Disease Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Region (2019-2030)
    Figure 21. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Region (2019-2030)
    Figure 22. North America Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
    Figure 28. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Type (2019-2030)
    Figure 29. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2030) & (US$/Unit)
    Figure 30. Global Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
    Figure 31. Global Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Application (2019-2030)
    Figure 32. Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2030) & (US$/Unit)
    Figure 33. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
    Figure 34. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
    Figure 35. North America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Country (2019-2030)
    Figure 36. North America Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Canada Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Mexico Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
    Figure 41. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
    Figure 42. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Country (2019-2030)
    Figure 43. Europe Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. France Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. United Kingdom Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Russia Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Italy Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Region (2019-2030)
    Figure 52. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Japan Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Korea Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. India Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Australia Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
    Figure 60. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
    Figure 61. South America Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Country (2019-2030)
    Figure 62. South America Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Country (2019-2030)
    Figure 63. Brazil Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Argentina Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
    Figure 66. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
    Figure 67. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales Quantity Market Share by Region (2019-2030)
    Figure 68. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Consumption Value Market Share by Region (2019-2030)
    Figure 69. Turkey Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Egypt Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Saudi Arabia Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. South Africa Drug-Coated Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Drug-Coated Balloon for Coronary Artery Disease Market Drivers
    Figure 74. Drug-Coated Balloon for Coronary Artery Disease Market Restraints
    Figure 75. Drug-Coated Balloon for Coronary Artery Disease Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Drug-Coated Balloon for Coronary Artery Disease in 2023
    Figure 78. Manufacturing Process Analysis of Drug-Coated Balloon for Coronary Artery Disease
    Figure 79. Drug-Coated Balloon for Coronary Artery Disease Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Companies Mentioned

B. Braun
Yinyi
Eurocor
Biotronic